Versant Venture Management, LLC
CIK 1560009 · Holdings on Jun 30, 2024 · First reported Aug 7, 2024
Top ten holdings
Q2 2024- CRSP34.84%
- CTNM20.92%
- 83086J20020.81%
- RPTX11.30%
- ADVM4.50%
- 7027121004.14%
- 39868T1052.85%
- ALGS0.66%
Share classes counted separately100.02%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- 83086J200Weight decreased · -9.64 pp30.45% → 20.81%Shares +2 (+0.00%)
- 39868T105Weight decreased · -6.02 pp8.87% → 2.85%Shares 0 (0.00%)
- ADVMWeight decreased · -2.45 pp6.95% → 4.50%Shares -1 (-0.00%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 8
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | CRSPCRISPR THERAPEUTICS AGCommon Shares View history and evidence | $26.93M | 34.84% | 498.56K shares | 32.95% → 34.84%+1.89 pp 0 (0.00%) | Unchanged | ↗▾ |
| 02 | CTNMCONTINEUM THERAPEUTICS INC-ACommon Stock View history and evidence | $16.17M | 20.92% | 918.16K shares | Prior unavailable +918.16K | New | ↗▾ |
| 03 | 83086J200Skye Bioscience, Inc.Common Stock View history and evidence | $16.08M | 20.81% | 2.01M shares | 30.45% → 20.81%-9.64 pp +2 (+0.00%) | Added | ↗▾ |
| 04 | RPTXREPARE THERAPEUTICS INCCommon Stock View history and evidence | $8.73M | 11.30% | 2.65M shares | 12.09% → 11.30%-0.79 pp 0 (0.00%) | Unchanged | ↗▾ |
| 05 | ADVMADVERUM BIOTECHNOLOGIES INCCommon Stock View history and evidence | $3.48M | 4.50% | 506.82K shares | 6.95% → 4.50%-2.45 pp -1 (-0.00%) | Reduced | ↗▾ |
| 06 | 702712100Passage Bio, Inc.Common Stock View history and evidence | $3.20M | 4.14% | 4.03M shares | 6.49% → 4.14%-2.35 pp -933.35K (-18.82%) | Reduced | ↗▾ |
| 07 | 39868T105GRITSTONE BIO INCCommon Stock View history and evidence | $2.20M | 2.85% | 3.56M shares | 8.87% → 2.85%-6.02 pp 0 (0.00%) | Unchanged | ↗▾ |
| 08 | ALGSALIGOS THERAPEUTICS INCCommon Stock View history and evidence | $510.28K | 0.66% | 1.46M shares | 2.20% → 0.66%-1.54 pp -862.44K (-37.17%) | Reduced | ↗▾ |
Options overlay 0
No options reported this quarter.
Exited positions 0
No exits reported this quarter.
Every number has a source.
CIK 1560009 · Period 2024-06-30
Data loaded 2026-09-23 · First reported 2024-08-07
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 77296930
}Take these holdings further.
This page includes 8 of 8 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 8 of 8 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1560009","quarter":"2024Q2","page_size":100}
get_institutional_manager_history
{"cik":"1560009","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.